New: Introducing the Finviz Futures Map

Serina Therapeutics, Inc.

Contributing Author

Recent Articles by Serina Therapeutics, Inc.

Aug-25	Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson's Disease under 505(b)(2) NDA Pathway SER GlobeNewswire
Aug-11	Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights SER GlobeNewswire
Jul-29	Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD) SER GlobeNewswire
Jul-28	Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference SER GlobeNewswire
Jul-10	Serina Therapeutics Makes Grant to New Employee Under Inducement Plan SER GlobeNewswire
Jul-01	Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting SER GlobeNewswire
Jun-23	Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025 SER GlobeNewswire
Jun-17	UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42 SER GlobeNewswire
Jun-17	Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42 SER GlobeNewswire
Jun-09	Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?" SER GlobeNewswire
May-22	Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors SER GlobeNewswire
May-14	Serina Therapeutics Makes Grants to New Employees Under Inducement Plan SER GlobeNewswire
May-08	Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights SER GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.